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Abstract
Typically twin studies are used to investigate the aggregate effects of genetic and environmental influences on brain
phenotypic measures. Although some phenotypic measures are highly heritable in twin studies, SNPs (single nucleotide
polymorphisms) identified by genome-wide association studies (GWAS) account for only a small fraction of the heritability
of these measures. We mapped the genetic variation (the proportion of phenotypic variance explained by variation among
SNPs) of volumes of pre-defined regions across the whole brain, as explained by 512,905 SNPs genotyped on 747 adult
participants from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). We found that 85% of the variance of intracranial
volume (ICV) (p = 0.04) was explained by considering all SNPs simultaneously, and after adjusting for ICV, total grey matter
(GM) and white matter (WM) volumes had genetic variation estimates near zero (p = 0.5). We found varying estimates of
genetic variation across 93 non-overlapping regions, with asymmetry in estimates between the left and right cerebral
hemispheres. Several regions reported in previous studies to be related to Alzheimer’s disease progression were estimated
to have a large proportion of volumetric variance explained by the SNPs.
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Introduction
The heritability of brain structure and function has received
extensive attention for many years, and it continues to be an area
of active research [1–4]. Many studies have used twin designs to
estimate the heritability of brain structure and function. Twin
studies typically compare the similarity of monozygotic twins
(MZ), who share the same genetic materials, to that of dizygotic
twins (DZ), who share 50% of their genes. Assuming equal
environmental exposure across zygosities, the known differences in
genetic similarity allow us to distinguish the effects of genes and
environment on a phenotype, including a phenotype characterized
using brain imaging measures.
Genome-wide association studies (GWAS) have discovered
hundreds of single-nucleotide polymorphisms (SNPs) that are
significantly associated with variation in brain structure and
function [5–11]. A study using the ADNI database found two
SNPs associated with temporal lobe volume [12] while two other
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ADNI studies found no SNPs associated with voxelwise volume
differences, after multiple comparison adjustment [13], and no
significant genes in a multivariate analysis combining the SNPs
into genes [14]; five SNPs were found to be significant in the
ADNI population for 142 various imaging phenotypes [15]. In
cases where significant SNPs are found in GWAS, however, those
SNPs typically explain only a small portion of overall phenotypic
variation. A question that has not been addressed fully for
phenotypic brain measures is where in the genome the missing
heritability resides. Explanations could include that causal variants
each may explain such a small amount of variation that their
effects do not reach stringent significance thresholds and/or that
the causal variants may not be in complete linkage disequilibrium
(LD) with the SNPs that have been genotyped. Heritability is
defined as the proportion of observed phenotypic variation that is
due to inherited genetic factors; GCTA (genome-wide complex
trait analysis) software allows us to approximate heritability with
the proportion of phenotypic variance explained by variation
among over 500,000 SNPs, after adjusting for environmental
factors. GCTA has been utilized previously to partition the genetic
variation of complex traits such as height and BMI into
contributions from each chromosome [16] and to estimate the
missing heritability of disease from GWAS [17].
Here we estimate the proportion of variance of 93 regional
volumes, as well as ICV, GM, WM, and cerebro-spinal fluid (CSF)
volumes, explained by 512,905 SNPs across the 22 autosomes
genotyped on 747 adult participants from the ADNI study.
Materials and Methods
Sample and Data
The NIH ADNI is an ongoing public-private partnership to test
whether genetic data, structural and functional neuroimaging, and
clinical data can be combined to measure the progression of mild
cognitive impairment (MCI) and early Alzheimer’s disease (AD).
The structural brain MRI data and corresponding clinical and
genetic data from baseline and follow-up were downloaded from
the ADNI publicly available database (http://adni.loni.ucla.edu/).
This initiative is a collective effort led by Principal Investigator
Michael Weiner, M.D., VA Medical Center and University of
California – San Francisco, involving many co-investigators and
recruitment of participants from over 50 sites in the United States
and Canada. More information on the study can be found at
www.adni-info.org.
The Human 610-Quad BeadChip (Illumina, Inc., San Diego,
CA) was used to genotype 818 participants in the ADNI database,
which resulted in a set of 620,901 SNP and copy number variation
(CNV) markers. Since the Apolipoprotein E (APOE) SNPs,
rs429358 and rs7412, are not on the Human 610-Quad Bead-
Chip, they were genotyped separately. These two SNPs together
define a 3 allele haplotype, namely the e2, e3, and e4 variants, and
the presence of each of these variants was available in the ADNI
database for all the individuals; the APOE gene has been the most
significant risk locus in GWAS of AD [18]. The software
EIGENSTRAT in the package of EIGENSOFT 3.0 was used to
calculate the population stratification coefficients of all partici-
pants. To reduce population stratification effects, we initially used
747 Caucasians out of the total 818 participants.
The MRI data were collected across a variety of 1.5 Tesla MRI
scanners with protocols individualized for each scanner, including
volumetric 3-dimensional sagittal MPRAGE or equivalent proto-
cols with varying resolutions. The typical protocol included:
repetition time (TR) = 2400 ms, inversion time (TI) = 1000 ms, flip
angle = 8u, field of view (FOV) = 24 cm, with a 256*256*170
acquisition matrix in the x-,y-, and z-dimensions yielding a voxel
size of 1.25*1.26*1.2 mm3. All original uncorrected image files are
available to the general scientific community, as described at
http://www.loni.ucla.edu/ADNI.
Image preprocessing and analysis
The MRI data were preprocessed using standard procedures
that included realignment to the anterior commissure and
posterior commissure by using MIPAV software, skull-stripping
by using Brain Surface Extractor (BSE) and Brain Extraction Tool
(BET), cerebellum removal, intensity inhomogeneity correction,
segmentation using the FSL-FAST software, and spatial co-
registration by using HAMMER [19–21]. Particularly, to establish
the longitudinal correspondences in the individual and the inter-
subject correspondences between the template and the individual,
we combined information across time points for each subject and
registered the images to a Jacob template [22] using a fully
automatic 4-dimensional atlas warping method called 4D
HAMMER [21]. Regional volumetric measurements and analyses
are then performed via measurements and analyses of the resulting
tissue density maps. Lastly, we carried out automatic regional
labeling: first, by labeling the template image and second, by
transferring the labels following the deformable registration of
subject images. After labeling 93 regions from the Jacob atlas, we
were able to compute volumes for each of these regions for each
subject.
Statistical Methods
GCTA (genome-wide complex trait analysis) [23] software
running a linear mixed model (LMM) was used to estimate the
proportion of variance of an observed phenotype that was
explained by a set of SNPs (rather than a single SNP, as in
GWAS), which we call genetic variation for simplicity. Here the
phenotypes of interest are the 93 regional volumes as well as total
intracranial (ICV), grey matter (GM), white matter (WM), and
cerebrospinal fluid (CSF) volumes, and the SNPs numbered
512,905 from 747 participants. Genetic relationship matrices
(GRMs) captured correlations across participants and were then
used to partition the phenotypic variance (see [23] for details). Via
GCTA, we fitted LMM separately to each of the 97 volumes as
dependent variables to estimate their genetic variation, as
explained by the 512,905 SNPs through GRMs. The volumes
were standardized to better fit the normal distribution assumed for
the LMM, and baseline age, gender, and the interaction of age
with gender were included as covariates, to capture variation due
to environmental effects. To adjust for population structure, we
also included subjects’ first ten principal components of the GRM
as covariates. ICV was also included as a covariate (for regions
other than ICV itself) to remove any potential scaling effects.
Within GCTA, we corrected for imperfect LD between the SNPs
on the array and causal variants by assuming the same allelic
distribution (i.e. minor allele frequency) for those causal variants
(which were potentially not in the SNP array) as that observed in
the included SNPs. See [24] for details on how the correction is
implemented within the GCTA software. This correction allows
for better approximation to true heritability within this observa-
tional study.
An R package, called APCluster, was used to group standar-
dized volumes into groups of similar regions based on the GCTA
measures. Affinity propagation (AP) clustering [25–26] was
applied first to the 93 non-overlapping regional (scaled and
standardized) volumes separately for each diagnostic group.
Clustering was based on the negative squared Euclidean similarity
matrix between the regional volumes, finding ‘‘exemplars’’ that
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were the centers of the clusters and iteratively determining the
number and membership of the clusters to maximize their ‘‘net
similarity,’’ an objective function that measures how represen-
tative the exemplars are of the data in each cluster. This
technique was then applied to cluster the genetic variation
estimates for the 93 non-overlapping regions. The vector of the
proportions of volumetric variance explained by all SNPs (after
adjusting for covariates) for the 93 non-overlapping regions was
clustered based on the squared distances of these genetic
variation estimates. Fisher’s exact tests were used to compare
clustering results: pair-wise between study groups and volu-
metric clustering compared to the clustering of genetic variation
estimates.
Results
Table 1 gives demographic information on the participants used
in these analyses. Age is similarly distributed for each of the
three study groups and there is a significant association between
gender and study group (p = 0.02); both age and gender were
adjusted for in each analysis. Tables 2 and 3 present genetic
variation estimates, their standard errors, the p-values from the
associated likelihood ratio tests (LRTs), and clustering results of
the estimates for all regions. Figure 1 shows genetic variation
estimates (top left) and the corresponding 2log10p-values from
the likelihood ratio tests (top right) for the standardized volumes
of each non-overlapping region as explained by the 512,905
SNPs across the entire genome, after adjusting for covariates.
Figure 2 shows genetic variation estimates in three dimensions.
Genetic variation estimates were found to be uncorrelated with
average region size (p = 0.2; from GLM with logit link function,
Normal distribution).
The AP cluster method identified 9, 10, and 10 clustering
groups within the 93 non-overlapping regional volumes for the
Control, MCI, and AD groups, respectively. Fisher’s exact tests of
independence yielded p,0.001 for each of the pairwise compar-
isons of clustering membership, indicating similarity between the
volumetric clustering results across the three groups. Subsequently
all participants were combined into a single analysis, yielding 9
clusters of regional volumes. In addition, AP clustering identified 6
groups of (non-overlapping) regions based on genetic contributions
to variation in their standardized, covariate-adjusted volumes (see
Table 2). Figure 1 shows the clustering map (bottom) for all of the
non-overlapping regions. A Fisher’s exact test yielded a p-value of
0.22 when testing for independence between the two sets of
clustering results (from the raw volumes and from the genetic
variation estimates), leading us to conclude that the groups that are
similar in volume are not necessarily similar in the proportion of
volumetric variance explained by the SNPs.
Discussion
GCTA findings showed that about 85% of intra-cranial volume
(ICV) variability and 57% of cerebrospinal fluid (CSF) volume
variability were explained by genetic variation within these
participants, with likelihood ratio tests (LRT) for the significance
of the random component yielding p-values of 0.04 and 0.12,
respectively. However, the genetic variation estimates for total
grey matter (GM) and white matter (WM) volumes (after adjusting
for ICV and other covariates) were both near zero. Previous
studies of adults reported similar estimates for ICV heritability
(73% in [27]; 81% in [28]; 79% in [29]; See [30] for a review).
Carmelli et al. [27] estimated heritability of CSF volumes to be
72% in their study of normal elderly twins, similar to our
estimates. We found markedly less genetic variation in our sample
for GM and WM volumes than did previous studies (WM: 73%
heritable in [27]; 62% in [29]; 69%–82% in WM regions and 55–
85% in GM regions in [4]), likely because of our adjusting for ICV
to remove scaling effects. Analysis of GM and WM volumes,
without adjusting for ICV, yielded genetic variation estimates of
41% (LRT p-value = 0.21) and 91% (LRT p-value = 0.02)
respectively, which are more consistent with published heritability
estimates, indicating that some of the previously published
heritability estimates for these volumes may be due to the
heritability of overall brain volume rather than genetic contribu-
tions that are specific to GM or WM.
In regional analyses, we found estimates that were asymmetric
across hemispheres, with no clear systematic difference between
left hemisphere and right hemisphere volumes. This is in
agreement with one prior report [31] and in a twin study of
schizophrenia [4] but at odds with another study that reported
symmetric heritability in only 10 monozygotic and 10 dizygotic
twin pairs, a sample that likely afforded insufficient statistical
Table 1. Participants’ gender and baseline age by study group.
Gender Age
Male Female Total Min 1st quartile Median Mean 3rd quartile Max
Normal 111 95 206 60 73 76 76 79 90
MCI 233 129 362 55 71 75 75 80 90
Alzheimer’s 98 81 179 55 71 77 75.5 81 91
Total 442 305 747 55 71 76 75.4 80 91
Gender and baseline age distribution by study group. Chi-squared test of independence between gender and study group yields a p-value of 0.02. ANOVA F-test for
differences in mean age between study groups yields a p-value of 0.18.
doi:10.1371/journal.pone.0071723.t001




variation Standard error LRT p-value
ICV 0.845 0.457 0.04
GM Volume ,0.001 0.476 0.5
WM Volume ,0.001 0.483 0.5
CSF Volume 0.574 0.468 0.12
Genetic variation estimates, standard errors, and associated likelihood ratio
tests for four aggregated volumes.
doi:10.1371/journal.pone.0071723.t002
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Table 3. Genetic variation estimates and associated clustering results for ROI volumes.
REGION Genetic Variation SE LRT p-value Cluster
LATERAL VENTRICLE RIGHT 0.999 0.468 0.017 1
GLOBUS PALLADUS RIGHT 0.907 0.440 0.024 1
CAUDATE NUCLEUS RIGHT 0.999 0.459 0.006 1
CUNEUS LEFT 0.999 0.462 0.010 1
NUCLEUS ACCUMBENS LEFT 0.894 0.494 0.053 1
LATERAL VENTRICLE LEFT 0.729 0.476 0.080 2
CAUDATE NUCLEUS LEFT 0.679 0.458 0.073 2
TEMPORAL LOBE WM RIGHT 0.743 0.473 0.068 2
OCCIPITAL LOBE WM LEFT 0.754 0.450 0.055 2
SUPERIOR PARIETAL LOBULE RIGHT 0.822 0.442 0.038 2
LATERAL OCCIPITOTEMPORAL GYRUS RIGHT 0.833 0.472 0.046 2
ENTORHINAL CORTEX RIGHT 0.785 0.442 0.040 2
CUNEUS RIGHT 0.766 0.455 0.050 2
INSULA RIGHT 0.595 0.449 0.094 3
PRECENTRAL GYRUS RIGHT 0.589 0.478 0.117 3
MEDIAL FRONTAL GYRUS LEFT 0.563 0.468 0.120 3
GLOBUS PALLADUS LEFT 0.581 0.483 0.127 3
PUTAMEN RIGHT 0.590 0.470 0.108 3
SUBTHALAMIC NUCLEUS RIGHT 0.586 0.465 0.105 3
OCCIPITAL LOBE WM RIGHT 0.628 0.473 0.102 3
PRECUNEUS LEFT 0.477 0.498 0.191 3
SUPERIOR FRONTAL GYRUS LEFT 0.626 0.462 0.094 3
POSTCENTRAL GYRUS LEFT 0.467 0.476 0.169 3
PERIRHINAL CORTEX RIGHT 0.544 0.464 0.122 3
POSTCENTRAL GYRUS RIGHT 0.569 0.459 0.110 3
LINGUAL GYRUS RIGHT 0.542 0.446 0.108 3
SUPERIOR TEMPORAL GYRUS RIGHT 0.499 0.486 0.165 3
FORNIX RIGHT 0.472 0.451 0.142 3
MIDDLE FRONTAL GYRUS RIGHT 0.263 0.491 0.306 4
INFERIOR FRONTAL GYRUS LEFT 0.266 0.456 0.276 4
ANGULAR GYRUS RIGHT 0.269 0.483 0.296 4
FRONTAL LOBE WM LEFT 0.274 0.475 0.286 4
POSTERIOR LIMB OF INTERNAL CAPSULE INC. CEREBRAL PEDUNCLE LEFT 0.334 0.492 0.261 4
POSTERIOR LIMB OF INTERNAL CAPSULE INC. CEREBRAL PEDUNCLE RIGHT 0.411 0.486 0.212 4
SUPERIOR PARIETAL LOBULE LEFT 0.320 0.478 0.260 4
PARIETAL LOBE WM LEFT 0.276 0.499 0.303 4
PRECENTRAL GYRUS LEFT 0.327 0.490 0.263 4
MEDIAL FRONT-ORBITAL GYRUS LEFT 0.392 0.456 0.195 4
PARIETAL LOBE WM RIGHT 0.291 0.474 0.273 4
PARAHIPPOCAMPAL GYRUS RIGHT 0.230 0.466 0.310 4
OCCIPITAL POLE RIGHT 0.288 0.472 0.275 4
INFERIOR TEMPORAL GYRUS RIGHT 0.293 0.474 0.270 4
MEDIAL FRONT-ORBITAL GYRUS RIGHT 0.176 0.468 0.353 5
SUPERIOR FRONTAL GYRUS RIGHT 0.153 0.497 0.386 5
PUTAMEN LEFT 0.182 0.465 0.346 5
PARAHIPPOCAMPAL GYRUS LEFT 0.112 0.483 0.411 5
FORNIX LEFT 0.205 0.482 0.341 5
PRECUNEUS RIGHT 0.148 0.489 0.386 5
SUPERIOR OCCIPITAL GYRUS RIGHT 0.135 0.453 0.379 5
SUPRAMARGINAL GYRUS LEFT 0.157 0.482 0.376 5
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power to detect differences in heritability across hemispheres [32].
Chen et al. [1] found bilateral symmetry across hemispheres in
their mapping of the brain’s cortical surface, but their study
involved 406 healthy twins and did not consider regional volumes.
We found the left and right cuneus to have significant genetic
variation (estimates of 99%, p = 0.01 and 77%, p = 0.05,
respectively); Niskanen et al. [33] found the cuneus to be involved
in the progression of AD, which could explain the genetic
variation in our study population. We also found the right caudate
nucleus to have significant genetic variation (estimate of 99%,
Table 3. Cont.
REGION Genetic Variation SE LRT p-value Cluster
MIDDLE FRONTAL GYRUS LEFT 0.160 0.481 0.373 5
SUPRAMARGINAL GYRUS RIGHT 0.085 0.489 0.434 5
INFERIOR FRONTAL GYRUS RIGHT 0.179 0.476 0.356 5
TEMPORAL LOBE WM LEFT 0.183 0.475 0.352 5
LATERAL FRONT-ORBITAL GYRUS LEFT 0.188 0.474 0.348 5
INSULA LEFT 0.156 0.458 0.365 5
MEDIAL FRONTAL GYRUS RIGHT 0.190 0.467 0.343 5
ANGULAR GYRUS LEFT 0.122 0.462 0.395 5
MEDIAL OCCIPITOTEMPORAL GYRUS RIGHT 0.131 0.473 0.392 5
LATERAL OCCIPITOTEMPORAL GYRUS LEFT 0.217 0.470 0.323 5
OCCIPITAL POLE LEFT 0.104 0.486 0.419 5
LATERAL FRONT-ORBITAL GYRUS RIGHT ,0.001 0.458 0.500 6
CINGULATE REGION RIGHT ,0.001 0.478 0.500 6
FRONTAL LOBE WM RIGHT ,0.001 0.471 0.500 6
TEMPORAL POLE RIGHT ,0.001 0.484 0.500 6
NUCLEUS ACCUMBENS RIGHT 0.059 0.488 0.454 6
UNCUS RIGHT ,0.001 0.490 0.500 6
CINGULATE REGION LEFT ,0.001 0.472 0.500 6
SUBTHALAMIC NUCLEUS LEFT ,0.001 0.466 0.500 6
HIPPOCAMPAL FORMATION RIGHT ,0.001 0.498 0.500 6
INFERIOR OCCIPITAL GYRUS LEFT ,0.001 0.457 0.500 6
ANTERIOR LIMB OF INTERNAL CAPSULE LEFT ,0.001 0.486 0.500 6
SUPERIOR TEMPORAL GYRUS LEFT ,0.001 0.472 0.500 6
UNCUS LEFT ,0.001 0.473 0.500 6
MIDDLE OCCIPITAL GYRUS RIGHT ,0.001 0.471 0.500 6
MIDDLE TEMPORAL GYRUS LEFT ,0.001 0.476 0.500 6
LINGUAL GYRUS LEFT ,0.001 0.425 0.500 6
PERIRHINAL CORTEX LEFT ,0.001 0.478 0.500 6
INFERIOR TEMPORAL GYRUS LEFT ,0.001 0.495 0.500 6
TEMPORAL POLE LEFT ,0.001 0.479 0.500 6
ENTORHINAL CORTEX LEFT ,0.001 0.491 0.500 6
INFERIOR OCCIPITAL GYRUS RIGHT ,0.001 0.463 0.500 6
SUPERIOR OCCIPITAL GYRUS LEFT 0.060 0.473 0.450 6
HIPPOCAMPAL FORMATION LEFT ,0.001 0.479 0.500 6
THALAMUS LEFT ,0.001 0.474 0.500 6
AMYGDALA LEFT ,0.001 0.484 0.500 6
MEDIAL OCCIPITOTEMPORAL GYRUS LEFT ,0.001 0.478 0.500 6
ANTERIOR LIMB OF INTERNAL CAPSULE RIGHT ,0.001 0.486 0.500 6
MIDDLE TEMPORAL GYRUS RIGHT ,0.001 0.480 0.500 6
CORPUS CALLOSUM ,0.001 0.488 0.500 6
AMYGDALA RIGHT ,0.001 0.505 0.500 6
MIDDLE OCCIPITAL GYRUS LEFT ,0.001 0.460 0.500 6
THALAMUS RIGHT ,0.001 0.473 0.500 6
Genetic variation estimates, standard errors, associated LRT p-values, and clustering results for 93 non-overlapping ROIs.
doi:10.1371/journal.pone.0071723.t003
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p = 0.02; left caudate nucleus: estimate of 68%, p = 0.07); this is a
region found previously to be significantly smaller in AD patients
than in normal controls [34], including in the ADNI population
[35], suggesting that size differences in the right hemisphere in AD
may be heritable.
The AP cluster analyses indicated the presence of 6 groups of
brain regions within the genetic variation estimates; the largest
group was comprised of those regions with little to no volumetric
variability explained by the SNPs. The clusters of regional volumes
differed significantly from the clusters of the corresponding genetic
variation estimates, but average regional volumes were not
associated significantly with genetic variation estimates. Thus,
the regions that were similar in size were not necessarily similar in
genetic variation, and there was no apparent relationship between
a region’s size and the genetic variation of the region.
In the current study, we systematically estimated the
variability of 93 non-overlapping regional volumes, ICV, and
GM, WM, and CSF volumes explained by 512,905 SNPs across
the 22 autosomes genotyped on 747 adult participants from
ADNI. These results give some evidence for a genetic
component of the variation between individuals in several
functional brain systems.
Figure 1. Genetic variation estimates and additional results for non-overlapping brain regions. Genetic variation estimates (top left; A)
and the associated 2log10p-values from LRT (top right; B). Hotter colors (black,red,white) indicate larger values. Clusters of genetic variation
estimates (below center; C) using AP cluster method.
doi:10.1371/journal.pone.0071723.g001
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First, there were several medial/mid-line brain structures with
high genetic variation estimates, including the bilateral medial
frontal-orbital gyrus, left medial frontal gyrus, bilateral precuneus,
right perirhinal cortex and right entorhinal cortex. These
structures, along with other medial neural regions, have been
characterized as being part of the default mode network (DMN) -
defined as a set of functionally connected brain regions that exhibit
task-induced deactivation and increase activity at rest [36–37].
DMN changes have been observed in MCI and AD, particularly
in the posterior region of medial parietal cortex referred to as the
precuneus [38]. Additionally, studies of resting glucose metabolism
have demonstrated hypometabolism in the inferior parietal lobule
that progresses with AD and correlates with mental status [39–40]
and is present in individuals at genetic risk for AD [41].
Second, many subcortical nuclei, as well as white matter tracts,
had large genetic variation estimates, including the right insula,
bilateral globus pallidus, bilateral putamen, bilateral caudate and
left nucleus accumbens. Many of these structures make up the
basal ganglia (i.e., globus pallidus, putamen, caudate nucleus,
nucleus accumbens), a group of nuclei that act as a cohesive
functional unit. The basal ganglia are associated with a variety of
functions, including motor control, procedural learning relating to
routine behaviors or ‘‘habits’’, eye movements, and emotional
functions [42]. Additionally, several theories implicate the basal
ganglia in action selection (i.e., deciding which of several possible
behaviors to execute at a given time [43–44]). Beyond the basal
ganglia, another subcortical region with high estimated genetic
variation was the insula, a structure believed to play a role in
functions usually linked to emotion (i.e., disgust) or the regulation
of the body’s homeostasis. Although changes in subcortical regions
are not the hallmark of MCI or AD, as AD is considered a cortical
dementia, the large estimates observed in the current study
indicate that future research in this area is warranted.
Finally, large genetic variation estimates were observed for two
prominent perceptual cortical pathways, namely the dorsal
‘‘where’’ pathway and the ventral ‘‘what’’ pathway. First described
by Ungerlieder and Mishkin [45], the dorsal pathway leads from
striate cortex to the parietal lobe and is responsible for determining
an object’s location in space, whereas the ventral pathway leads
from striate cortex to the temporal lobe and is responsible for
determining an object’s identity. Via an interaction between
bottom-up (visual perceptual information) and top-down (knowl-
edge information) processing these pathways are utilized to rapidly
to perceive ‘‘what’’ objects are in an environment and ‘‘where’’
those objects are spatially located relative to the observer. Given
the clear adaptive nature of such visual processing streams, it is
perhaps unsurprising that large genetic variation estimates were
observed for several key regions that comprise these pathways,
including bilateral occipital white matter tracts, bilateral occipital
pole, bilateral temporal lobe white matter tracts, bilateral parietal
lobe white matter tracts, bilateral superior parietal lobule and
bilateral occipito-temporal gyrus.
Due to a lack of power in the likelihood-ratio testing procedure
and a sample size that was not sufficiently large to make standard
Figure 2. 3-dimensional map of genetic variation estimates. Views (clockwise from top left): right lateral (A), anterior (B), superior (C), inferior
(F), posterior (E), and left lateral (D). Hotter colors (black,red,white) indicate larger values.
doi:10.1371/journal.pone.0071723.g002
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errors small, we did not find estimates to be highly statistically
significant. We did not perform multiple comparisons adjust-
ments on the p-values from these analyses, in order to preserve
the ability to compare results across different brain regions.
Here our goal is to map genetic variation across the entire brain,
where the results of particular interest are the comparisons of
genetic variation among different regional volumes. The mixed
model approach utilized by GCTA allows for an approximation
to total heritability based on a large number of SNPs; this
methodology is validated by the comparison of our results to
published twin studies that estimate ‘‘true’’ heritability and have
similar findings. Estimates of 0.999 for three regions do not
imply that over 99% of variation in those volumes is explained
by genetic variability, but they likely indicate large true
parameter values (i.e. volumetric variance explained by the
SNPs) and some additional variation due to the (case-control)
sampling scheme, as well as noise in the volumetric data.
Although our findings agree with those from a number of
published twin studies, some of our findings could derive from our
study population, in that some of the genetic contribution to the
progression of AD could have contributed to the genetic variation
we detected. We found significant but asymmetric genetic
variation estimates in regions previously reported to be related
to AD, and we found that much of the heritability of overall GM
and WM volumes may be due to the heritability of total ICV
rather than from specific genetic contributions to GM or WM
volumes. In the future, large twin studies in elderly patients could
compare these regions in their heritability and assess their
relationship with the progression of Alzheimer’s disease.
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